SB16

denosumab · Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB16, covering 2025-01-09 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis [Phase 3]

See pricing